Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy in Patients with Triple Negative Breast Cancer

BACKGROUND: Heterogeneity exists in triple negative breast cancer (TNBC) response to standard anthracycline/taxane based neoadjuvant systemic therapy (NAST) with 40–50% of patients having pathologic complete response to therapy (pCR). Early assessment of imaging response during NAST may identify a s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer
Hauptverfasser: Adrada, Beatriz E., Candelaria, Rosalind, Moulder, Stacy, Thompson, Alastair, Wei, Peng, Whitman, Gary J., Valero, Vicente, Litton, Jennifer K., Santiago, Lumarie, Scoggins, Marion E., Moseley, Tanya, White, Jason B, Ravenberg, Elizabeth. E, Yang, Wei T., Rauch, Gaiane M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319084/
https://ncbi.nlm.nih.gov/pubmed/33878210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33604
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge